These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20301105)

  • 1. Comprehensive plasma-screening for known and unknown substances in doping controls.
    Thomas A; Guddat S; Kohler M; Krug O; Schänzer W; Petrou M; Thevis M
    Rapid Commun Mass Spectrom; 2010 Apr; 24(8):1124-32. PubMed ID: 20301105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer.
    Thomas A; Geyer H; Schänzer W; Crone C; Kellmann M; Moehring T; Thevis M
    Anal Bioanal Chem; 2012 May; 403(5):1279-89. PubMed ID: 22231507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
    Thomas A; Solymos E; Schänzer W; Baume N; Saugy M; Dellanna F; Thevis M
    Anal Chim Acta; 2011 Nov; 707(1-2):107-13. PubMed ID: 22027126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
    Thevis M; Guddat S; Schänzer W
    Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2012 Mar; 47(3):381-91. PubMed ID: 22431466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.
    Thomas A; Kohler M; Schänzer W; Kamber M; Delahaut P; Thevis M
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
    Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Bredehöft M; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry.
    Thevis M; Krug O; Schänzer W
    J Mass Spectrom; 2006 Mar; 41(3):332-8. PubMed ID: 16421876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
    Thevis M; Wilkens F; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(22):3393-402. PubMed ID: 17051614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
    Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
    Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.
    Thomas A; Walpurgis K; Krug O; Schänzer W; Thevis M
    J Chromatogr A; 2012 Oct; 1259():251-7. PubMed ID: 22901302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis.
    Van Thuyne W; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2008 Nov; 1210(2):193-202. PubMed ID: 18849031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
    Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.